01/09/2026
A legal storm is engulfing CeraVe, celebrated nationwide as the number one dermatologist-recommended skincare brand in the United States. The cosmetics giant and its parent company, L’Oreal, are facing six federal class-action lawsuits consolidated in the Southern District of New York over allegations that hidden carcinogens lurk within their formulas. At the dark heart of these legal battles is benzene—a notorious Group 1 human carcinogen directly linked to leukemia and blood cancers. Independent laboratory testing by Valisure ignited panic revealing that certain CeraVe cleansers harbored benzene levels ranging from 5 to 12 parts per million (ppm), which drastically violates the U.S. Food and Drug Administration’s strict safety threshold of 2 ppm.
The legal complaints target two specific acne treatments: the CeraVe Acne Foaming Cream Cleanser and the Acne Foaming Cream Wash. The lawsuits do not claim that CeraVe intentionally added the toxic chemical; instead, they allege that the products’ active ingredient, benzoyl peroxide, is fundamentally unstable and naturally degrades into benzene when exposed to everyday heat, warehouse storage, or even human body temperature. This litigation highlights a devastating corporate failure to properly warn unsuspecting consumers about the chemical breakdown happening right on their bathroom counters.